Literature DB >> 26158608

Progress of Diabetic Severity and Risk of Dementia.

Wei-Che Chiu1, Wen-Chao Ho1, Ding-Lieh Liao1, Meng-Hung Lin1, Chih-Chiang Chiu1, Yu-Ping Su1, Pau-Chung Chen1.   

Abstract

CONTEXT: Diabetes is a risk factor for dementia, but the effects of diabetic severity on dementia are unclear.
OBJECTIVE: The purpose of this study was to investigate the association between the severity and progress of diabetes and the risk of dementia. DESIGN AND
SETTING: We conducted a 12-year population-based cohort study of new-onset diabetic patients from the Taiwan National Health Insurance Research Database. The diabetic severity was evaluated by the adapted Diabetes Complications Severity Index (aDCSI) from the prediabetic period to the end of follow-up. Cox proportional hazard regressions were used to calculate the hazard ratios (HRs) of the scores and change in the aDCSI. PARTICIPANTS: Participants were 431,178 new-onset diabetic patients who were older than 50 years and had to receive antidiabetic medications. MAIN OUTCOME: Dementia cases were identified by International Classification of Diseases, ninth revision, code (International Classification of Diseases, ninth revision, codes 290.0, 290.1, 290.2, 290.3, 290.4, 294.1, 331.0), and the date of the initial dementia diagnosis was used as the index date.
RESULTS: The scores and change in the aDCSI were associated with the risk of dementia when adjusting for patient factors, comorbidity, antidiabetic drugs, and drug adherence. At the end of the follow-up, the risks for dementia were 1.04, 1.40, 1.54, and 1.70 (P < .001 for trend) in patients with an aDCSI score of 1, 2, 3, and greater than 3, respectively. Compared with the mildly progressive patients, the adjusted HRs increased as the aDCSI increased (2 y HRs: 1.30, 1.53, and 1.97; final HRs: 2.38, 6.95, and 24.0 with the change in the aDCSI score per year: 0.51-1.00, 1.01-2.00, and > 2.00 vs < 0.50 with P < .001 for trend).
CONCLUSIONS: The diabetic severity and progression reflected the risk of dementia, and the early change in the aDCSI could predict the risk of dementia in new-onset diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26158608     DOI: 10.1210/jc.2015-1677

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes.

Authors:  Laura M Raffield; Gretchen A Brenes; Amanda J Cox; Barry I Freedman; Christina E Hugenschmidt; Fang-Chi Hsu; Jianzhao Xu; Benjamin C Wagner; Jeff D Williamson; Joseph A Maldjian; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2015-09-25       Impact factor: 2.852

2.  Dose-Response Association of Metformin with Parkinson's Disease Odds in Type 2 Diabetes Mellitus.

Authors:  Kuang-Hua Huang; Ya-Lan Chang; Shuo-Yan Gau; Tung-Han Tsai; Chien-Ying Lee
Journal:  Pharmaceutics       Date:  2022-04-27       Impact factor: 6.525

3.  Vascular complications of diabetes: natural history and corresponding risks of dementia in a national cohort of adults with diabetes.

Authors:  Po-Yin Chang; I-T Ing Wang; Chern-En Chiang; Chen-Huan Chen; Wan-Yu Yeh; Victor W Henderson; Yi-Wen Tsai; Hao-Min Cheng
Journal:  Acta Diabetol       Date:  2021-02-23       Impact factor: 4.280

Review 4.  The diabetic brain and cognition.

Authors:  Peter Riederer; Amos D Korczyn; Sameh S Ali; Ovidiu Bajenaru; Mun Seong Choi; Michael Chopp; Vesna Dermanovic-Dobrota; Edna Grünblatt; Kurt A Jellinger; Mohammad Amjad Kamal; Warda Kamal; Jerzy Leszek; Tanja Maria Sheldrick-Michel; Gohar Mushtaq; Bernard Meglic; Rachel Natovich; Zvezdan Pirtosek; Martin Rakusa; Melita Salkovic-Petrisic; Reinhold Schmidt; Angelika Schmitt; G Ramachandra Sridhar; László Vécsei; Zyta Beata Wojszel; Hakan Yaman; Zheng G Zhang; Tali Cukierman-Yaffe
Journal:  J Neural Transm (Vienna)       Date:  2017-08-01       Impact factor: 3.575

5.  Risk of allergic conjunctivitis in patients with type 1 diabetes mellitus: a population-based retrospective cohort study.

Authors:  Yin-Huei Chen; Cheng-Li Lin; Da-Tian Bau; Yi-Chih Hung
Journal:  BMJ Open       Date:  2017-06-19       Impact factor: 2.692

6.  Diabetes duration and the risk of dementia: a cohort study based on German health claims data.

Authors:  Constantin Reinke; Nikolaus Buchmann; Anne Fink; Christina Tegeler; Ilja Demuth; Gabriele Doblhammer
Journal:  Age Ageing       Date:  2022-01-06       Impact factor: 10.668

7.  Potential of prevention strategies for the modifiable risk factor type 2 diabetes with relation to the future number of dementia patients in Germany- a multi-state projection through 2040.

Authors:  Anne Fink; Achim Doerre; Ilja Demuth; Gabriele Doblhammer
Journal:  BMC Neurol       Date:  2022-04-26       Impact factor: 2.903

8.  Frailty modifies the association between opioid use and mortality in chronic kidney disease patients with diabetes: a population-based cohort study.

Authors:  Szu-Ying Lee; Jui Wang; Chia-Ter Chao; Kuo-Liong Chien; Jenq-Wen Huang
Journal:  Aging (Albany NY)       Date:  2020-11-07       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.